We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You canĀ read more about our cookies before you choose.
Percutaneous patent foraman ovale closure for the prevention of recurrent cerebral embolic stroke in adults (around the age 60 years and under)
NHS England has carefully reviewed the evidence to treat patent foramen ovale with percutaneous PFO closure in those adults who have had a previous ischaemic stroke. We have concluded that there is enough evidence to make the treatment available.